JP2014526681A5 - - Google Patents

Download PDF

Info

Publication number
JP2014526681A5
JP2014526681A5 JP2014529131A JP2014529131A JP2014526681A5 JP 2014526681 A5 JP2014526681 A5 JP 2014526681A5 JP 2014529131 A JP2014529131 A JP 2014529131A JP 2014529131 A JP2014529131 A JP 2014529131A JP 2014526681 A5 JP2014526681 A5 JP 2014526681A5
Authority
JP
Japan
Prior art keywords
subject
hematopoietic toxicity
biomarker
group
dinitrobenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014529131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014526681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/054731 external-priority patent/WO2013038341A1/en
Publication of JP2014526681A publication Critical patent/JP2014526681A/ja
Publication of JP2014526681A5 publication Critical patent/JP2014526681A5/ja
Pending legal-status Critical Current

Links

JP2014529131A 2011-09-13 2012-09-12 造血毒性を評価するための手段及び方法 Pending JP2014526681A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161533867P 2011-09-13 2011-09-13
EP11181156 2011-09-13
US61/533,867 2011-09-13
EP11181156.8 2011-09-13
PCT/IB2012/054731 WO2013038341A1 (en) 2011-09-13 2012-09-12 Means and methods for assessing hematopoietic toxicity

Publications (2)

Publication Number Publication Date
JP2014526681A JP2014526681A (ja) 2014-10-06
JP2014526681A5 true JP2014526681A5 (https=) 2015-11-05

Family

ID=47882692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014529131A Pending JP2014526681A (ja) 2011-09-13 2012-09-12 造血毒性を評価するための手段及び方法

Country Status (10)

Country Link
US (1) US20150037825A1 (https=)
EP (1) EP2756301A4 (https=)
JP (1) JP2014526681A (https=)
KR (1) KR20140059805A (https=)
CN (2) CN106053832A (https=)
AU (1) AU2012310147A1 (https=)
BR (1) BR112014005472A2 (https=)
CA (1) CA2845621A1 (https=)
IL (1) IL231007A0 (https=)
WO (1) WO2013038341A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114594192A (zh) * 2022-03-07 2022-06-07 山东大学 一种泊沙康唑起始物料中氯苯胺和氯硝基苯胺同分异构体的检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112409B2 (en) * 1999-01-29 2006-09-26 Center For Molecular Medicine And Immunology Method of determining cytokine dosage for myelosuppressive state
JP2003245076A (ja) * 2001-01-30 2003-09-02 Takeda Chem Ind Ltd 新規タンパク質およびそのdna
AU2003258319B2 (en) * 2002-08-21 2009-09-17 Hemogenix, Inc. High-throughput assay of hematopoietic stem and progenitor cell proliferation
US20040121305A1 (en) * 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
US8034613B2 (en) * 2005-06-01 2011-10-11 Wisconsin Alumni Research Foundation Multipotent lymphohematopoietic progenitor cells
CN101529249A (zh) * 2006-08-30 2009-09-09 梅坦诺米克斯有限公司 用于诊断溶血性贫血的工具和方法
US7689187B2 (en) * 2007-03-01 2010-03-30 Motorola, Inc. Dual input low noise amplifier for multi-band operation
US8062222B2 (en) * 2007-06-13 2011-11-22 Litron Laboratories, Ltd. Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
WO2009153136A2 (en) * 2008-05-28 2009-12-23 Basf Se Means and methods for assessing liver toxicity

Similar Documents

Publication Publication Date Title
Wang et al. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease
Mondello et al. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
JP6692422B2 (ja) 尿中代謝物による疾病診断法
JP2017524130A5 (https=)
JP2009501333A5 (https=)
JP2017504011A5 (https=)
Powell et al. Neuroinflammatory biomarkers associated with mild traumatic brain injury history in special operations forces combat soldiers
BR112014005651A2 (pt) aparelho de diagnóstico
Sinha et al. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach
JP2018529931A5 (https=)
JPWO2016047677A1 (ja) うつ病治療薬の選択肢を予測する方法
JP2014530350A5 (https=)
JP2018536170A5 (https=)
RU2013158667A (ru) Способ диагностики болезни гоше
WO2015030211A1 (ja) 疲労のバイオマーカーおよびその利用
JP2019510974A5 (https=)
Lidbury et al. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis
JP2014526681A5 (https=)
Karam et al. Whole-blood validation of a new point-of-care equine serum amyloid A assay
TWI735470B (zh) 糖尿病性腎病之判定方法、及於此種判定方法中生物標記之用途
Garrett et al. Evaluation of buffy coat smears for circulating mast cells in healthy cats and ill cats without mast cell tumor–related disease
Selleri et al. Point-of-care blood gases, electrolytes, chemistries, hemoglobin, and hematocrit measurement in venous samples from pet rabbits
WO2022271865A9 (en) Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
US7056745B2 (en) Diagnostic method and apparatus
JP6865280B2 (ja) ヘリコバクター・ピロリ胃炎および萎縮性胃炎と関連リスクの改善された検出方法